Reliability of Bioimpedance Spectroscopy and Tonometry after Breast Conserving Cancer Treatment

Moseley, Amanda; Piller, Neil

doi:10.1089/lrb.2008.1002

Cited by 39 publications

(36 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 While various methods exist for measuring arm lymphedema, 4 measurement of breast and trunk lymphedema remains challenging. 5 Another challenge in the measurement of lymphedema, regardless of where it manifests, is the assessment of lymphedema composition. Soft tissues affected by lymphedema can change over time, from initially an extracellular fluid-rich edematous stage through to a largely fibrotic condition.…”

Section: Introductionmentioning

confidence: 99%

Assessment of Breast Cancer-Related Lymphedema: A Comparison of Moisture Meter and Spot Bioimpedance Measurement

Czerniec

Ward

Kilbreath

2015

Lymphatic Research and Biology

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of Breast Cancer-Related Lymphedema: A Comparison of Moisture Meter and Spot Bioimpedance Measurement

Czerniec

Ward

Kilbreath

2015

Lymphatic Research and Biology

View full text Add to dashboard Cite

show abstract

“…A study in women with breast cancer evaluated the reliability of bioimpedance spectroscopy (BIS) to determine breast tissue density and fluid changes that could aid in the early diagnosis of breast edema and lymphedema which are precursors to the development of breast cancer. 23 The BIS measurements were repeated in triplicate in 14 women after breast conserving surgery in combination with chemotherapy and/or radiation therapy and measurements were compared with the healthy breast of each woman. The electrodes were applied locally to both breasts.…”

Section: Methodsmentioning

confidence: 99%

The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients—a comprehensive review

Grundmann

Yoon

Williams³

2015

Eur J Clin Nutr

132

View full text Add to dashboard Cite

Bioelectrical impedance analysis (BIA) and especially its derived parameter phase angle have been widely used in different populations. The variability of BIA measures has often been cited as a major limitation for its clinical use in evaluating nutritional status and overall health of patients. Cancer patients often present with malnourishment and cachexia, which complicate the course of treatment and affect outcomes. PubMed, CINAHL, EBSCO and Cochrane Library have been searched for relevant publications in English for BIA in cancer patients. Out of 197 total results, 27 original research articles related to BIA measures in cancer patients were included in this review. Studies indicate that the use of BIA and phase angle measures can benefit in the clinical management of cancer patients in multiple ways: in the prevention; diagnosis; prognosis; and outcomes related to treatments that affect nutritional and overall health status. Phase angle and fat-free mass measures were most commonly evaluated and correlated with nutritional status and survival rate. One limitation of BIA measures is the high interpatient variability which requires careful interpretation of results in the context of the individual patient rather than comparison with population data. The BIA and phase angle provide practitioners for the evaluation of nutritional and overall health status in cancer patients with a convenient and non-invasive technique and should be encouraged.

show abstract

“…BIS and the dielectric constant may be useful in defining those at risk patients with Stage 0 lymphedema and to help define the efficacy and physiologic changes resulting from various treatment modalities. Lastly, tissue tonometry measures the resistance of tissues to compression and quantifies tissue compliance; the degree of compressibility can then be correlated with limb swelling [31,34].…”

Section: Diagnosis and Assessmentmentioning

confidence: 99%

Lymphedema: How Do We Diagnose and Reduce the Risk of This Dreaded Complication of Breast Cancer Treatment?

Bernas

Askew

Armer

et al. 2010

Curr Breast Cancer Rep

View full text Add to dashboard Cite

Lymphedema is an under-recognized, progressive, life-long condition estimated to impact 2-3 million people in the United States. The incidence of breast cancer related lymphedema varies greatly in the literature largely due to different measurement techniques, competing thresholds for defining lymphedema, and variation in length of follow-up. Multiple imaging techniques have become useful for diagnosis. Lymphoscintigraphy is one of the most commonly used, as it can identify pathways of lymphatic drainage, quantify extent of dermal backflow, and help determine functional and morphologic changes in the lymphatic system. Early detection and intervention hold the greatest promise of reducing the incidence of lymphedema. Health care providers involved with cancer patients need to become more educated about lymphedema, aware of current riskreduction practices, and familiar with methods of diagnosis and assessment, so that patients with early swelling can be referred to lymphedema treatment specialists at a time when treatment is more effective.

show abstract

Reliability of Bioimpedance Spectroscopy and Tonometry after Breast Conserving Cancer Treatment

Abstract: The reliability of these two measurement techniques provides an opportunity for researchers and clinicians to easily quantify breast tissue and fluid changes which in turn may lead to the earlier diagnosis and targeted treatment of breast edema and lymphedema.

Cited by 39 publications

References 12 publications

Assessment of Breast Cancer-Related Lymphedema: A Comparison of Moisture Meter and Spot Bioimpedance Measurement

Assessment of Breast Cancer-Related Lymphedema: A Comparison of Moisture Meter and Spot Bioimpedance Measurement

The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients—a comprehensive review

Lymphedema: How Do We Diagnose and Reduce the Risk of This Dreaded Complication of Breast Cancer Treatment?

Contact Info

Product

Resources

About